Biolinq Incorporated
https://www.biolinq.me/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Biolinq Incorporated
News We're Watching: Abbott, Click, Otsuka, Prenosis Win FDA Approval; EU Health Data Space Proposal, And More
This week, Abbott, Click and Otsuka, Prenosis won the FDA nod respectively for an in vitro diagnostic to evaluate patients for concussion, the first prescription digital therapeutic to treat major depressive disorder and a software to predict sepsis. Also on the regulatory front, the FDA will now take 513(g)s forms via its eSTAR framework. In Europe, the debate of what personal information can be shared continues.
Bring Naloxone To Opioid Overdoses: FDA Crowd-Sources Smartphone Apps
FDA announces $40,000 Naloxone App Competition at the start of Prescription Opioid and Heroin Epidemic Awareness Week through Sept. 23, when registration open for the competition, which closes Oct. 7.
Dealmaking Roundup February 2007
Summary of recent device mergers and acquisitions, alliances, and financings.
Recent Financings of Private Companies (02/2007)
Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.
Company Information
- Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Other Names / Subsidiaries
-
- Electrozyme, LLC
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice